Comparison of the [F]-FDG and [F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma.

Fiche publication


Date publication

avril 2021

Journal

Molecular imaging and biology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BRASSE David, Pr LAQUERRIERE Patrice, Dr ROUSSEAU Marc, Dr BURCKEL Hélène, Dr FINCK Christian


Tous les auteurs :
Brasse D, Burckel H, Marchand P, Rousseau M, Ouadi A, Vanstalle M, Finck C, Laquerriere P, Boisson F

Résumé

The main objective of the present study was to compare the 2-deoxy-2-[F]fluoro-D-glucose ([F]-FDG) and 3'-[F]fluoro-3'-deoxythymidine ([F]-FLT) PET imaging biomarkers for the longitudinal follow-up of small animal proton therapy studies in the context of hepatocellular carcinoma (HCC).

Mots clés

Hepatocellular carcinoma, Longitudinal study, PET, Preclinical studies, Proton therapy

Référence

Mol Imaging Biol. 2021 Apr 13;: